We are live on ! Find out more
CANO.WS

Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150

Delisted

CANO.WS was delisted on the 9th of November, 2023.

33 hedge funds and large institutions have $42.6M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

18% more funds holding

Funds holding: 2833 (+5)

45% less capital invested

Capital invested by funds: $77.2M → $42.6M (-$34.6M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
33
Holders Change
+5
Holders Change %
+17.86%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
10
Increased
6
Reduced
4
Closed
4
Calls
$6.19M
Puts
Net Calls
+$6.19M
Net Calls Change
-$1.54M
Name Holding Trade Value Shares
Change
Change in
Stake
SM
26
Skaana Management
New York
$106K +$134K +44,281 New
BCM
27
Bluefin Capital Management
New York
$41K +$51.6K +17,016 New
Jane Street
28
Jane Street
New York
$26K -$10.5K -3,451 -24%
JAIC
29
Josh Arnold Investment Consultant
Minnesota
$24K +$30.9K +10,200 New
UBS Group
30
UBS Group
Switzerland
$5K +$6.75K +2,227 New
Morgan Stanley
31
Morgan Stanley
New York
$2K -$15.1K -4,989 -83%
AIMCA
32
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$1.94M -469,875 Closed
MP
33
Mangrove Partners
Connecticut
-$3.91M -308,663 Closed
MIM
34
Monashee Investment Management
Massachusetts
-$413K -99,999 Closed
M
35
Murchinson
Ontario, Canada
-$118K -28,550 Closed

CANO.WS Hedge Fund Activity: Q4 2021 in Review

33 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q4 2021, worth a combined $42.6M — down 45% from $77.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CANO.WS positions and 4 closed out — a net gain of 6 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Walleye Capital, adding an estimated $1.14M. The largest seller was Mangrove Partners, exiting entirely with an estimated $3.91M sold.

  • 33 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q4 2021, up from 28 in Q3 2021.
  • Funds reported $42.6M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q4 2021, down 45% quarter-over-quarter.
  • 10 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q4 2021 and 4 closed out, a net change of +6 holders.
  • The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q4 2021 was Walleye Capital, an estimated $1.14M added.
  • The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q4 2021 was Mangrove Partners, an estimated $3.91M sold.

Based on aggregated 13F filings for Q4 2021.